Fabrinet Ordinary Shares (FN)
Live price chart, market sentiment, and community perspectives for Fabrinet (NYSE: FN).
Live price chart, market sentiment, and community perspectives for Fabrinet (NYSE: FN).
On our desk, we are seeing solid buying interest supported by a trailing P/E of 34.0 and strong fiscal 2026 revenue of $4.64 billion. However, the recent price dip following the August earnings release tells us that market participants are closely monitoring the sharp contraction in free cash flow down to $4.2 million due to heavy capital expenditure borrowing.
From a risk management standpoint, the divergence between accelerating non-GAAP EPS and compressed free cash flow requires careful tracking. Fabrinet's underlying fundamentals in optical packaging are impressive, but taking on debt for facility expansions introduces execution risk that needs hedging via protective put options.
When evaluating optical manufacturing setups, candidates and analysts must focus on Fabrinet's execution capacity in datacom. Management's commentary regarding ramping customer agreements points to persistent tailwinds, yet operational efficiency must keep pace with rising capital requirements.
Looking at the quantitative models, FN holds an average score around 63 with a 1-year momentum uptrend of roughly 34 to 37 percent. Valuation metrics show a trailing P/E near 37.4x and a forward P/E around 25.1x, signaling that the stock is priced for perfection while dealing with tighter cash conversion cycles.
As a hedge fund portfolio manager, I find Fabrinet's positioning in precision optical and electronic manufacturing extremely attractive for secular data center trends. Yet, the lack of a dividend yield and zero reported debt-to-equity data fields in standard snapshots mean we must dig deeper into their upcoming 10-K to assess balance sheet leverage accurately.
Explore plasma cleansing, somatic organ swaps, and BCI.